CCL2 activation and subsequent secretion by bladder cancer cells in turn upregulates VEGF-C expression in tumor-associated macrophages, promoting lymphangiogenesis and lymphatic metastasis [104]. The gene discussed is CCL2; the disease is urinary bladder cancer.